News

Rising Tide Foundation for Clinical Cancer Research – CALL for REVIEWERS 2023 February 2, 2023 For our Grant Review Committee, we are looking for reviewers for clinical cancer research proposals.   We seek Patient Research Advocates with experience in reviewing grant applications and personal experience on:    renal cancer melanoma Grant applications will be available for […]

Improving patient care for older men/adults with metastatic prostate cancer January 24, 2023 The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) is supporting the opening of a new clinical trial at the University Health Network in Toronto, Canada. The trial, led by Dr Shabbir Alibhai, aims at improving the care of older patients suffering

Rising Tide Foundation’s newest initiative: the Spark Fund for Collaboration January 19, 2023 Following an expression of interest by grantees to collaborate on existing and future projects, Rising Tide Foundation launched the Spark Fund for Collaboration – a designated fund for former and current RTF grantees to develop and test ideas for collaboration between at

Match-making service request for proposals December 22, 2022 RTFCCR would like to invite proposals from a consortium (comprised of medical/research organizations and at least three patient organizations which are cancer focused) to advance creation of an international patient involvement match-making platform.  The grant provided to the winning proposal(s) is up to USD 300,000.   Background

Innovative study testing AI for radiotherapy planning opens: the ARCHERY Study November 10, 2022 A new study testing an innovative approach to radiotherapy treatment planning is opening: the ARCHERY study evaluates the use of artificial intelligence (AI) to automate several steps in the radiotherapy treatment pathway. It will assess both its quality, time and cost savings compared

Rising Tide celebrates Breast Cancer Awareness Month October 27, 2022 October is #BreastCancerAwarenessMonth. Rising Tide Foundation for Clinical Cancer Research (RTFCCR) wants to thank its present & past grantees working to address various aspects of this devastating disease, with the goal of bringing better options to patients. Our big THANK YOU goes to:   Dr. Olivia Pagani,